A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

NCT00993031 ·Status: COMPLETED ·Phase: PHASE3

Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs

NCT04140266 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

NCT04862975 ·Status: COMPLETED

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

NCT00936195 ·Status: WITHDRAWN ·Phase: PHASE3

Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women

NCT03227731 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth

NCT00001007 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

NCT00000808 ·Status: COMPLETED ·Phase: PHASE1

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

NCT00074412 ·Status: COMPLETED ·Phase: PHASE3

A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding

NCT00146380 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed

NCT05642481 ·Status: COMPLETED

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

NCT00530777 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

NCT04518228 ·Status: COMPLETED

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

NCT02256631 ·Status: COMPLETED ·Phase: PHASE1

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

NCT00246610 ·Status: COMPLETED ·Phase: PHASE4

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

NCT00719602 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection

NCT00000716 ·Status: COMPLETED ·Phase: PHASE2

Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.

NCT00000830 ·Status: COMPLETED

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

NCT00115648 ·Status: COMPLETED ·Phase: PHASE3

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

NCT00017719 ·Status: COMPLETED ·Phase: PHASE3

Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine

NCT00000828 ·Status: COMPLETED

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

NCT02778204 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

NCT00000952 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

NCT01251601 ·Status: WITHDRAWN

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

NCT06517693 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

NCT00000887 ·Status: COMPLETED ·Phase: PHASE1